Indian Immunologicals invests Rs 75 crore to set up new Sterile Filling Facility in Telangana Farhat Nasim25 Jun 2019 6:06 AM GMTWith this investment of Rs 75 crores in the upcoming filling facility, Indian Immunologicals Limited expects to increase its capacity to supply...
Caplin Point's sterile injectable site in Chennai gets two USFDA observations Medical Dialogues Bureau20 Jun 2019 8:04 AM GMTNew Delhi: Caplin Point Laboratories Monday said the US health regulator has made two observations after completion of inspection at its subsidiary's...
China province eyeing investment opportunities in Indian medical sector Medical Dialogues Bureau16 Jun 2019 3:45 AM GMT"There is a great opportunity to work in industries such as medical and IT between India and Yunnan. There are many business councils and associations...
Japanese regulator PMDA completes inspection of Lupin Mandideep facility unit, no major observations Medical Dialogues Bureau6 Jun 2019 8:35 AM GMTNew Delhi: Drug firm Lupin Tuesday said Japanese regulatory agency, PMDA, has concluded the inspection of Unit 2 at Mandideep facility in Madhya...
AstraZeneca opens new development operations centre in Bengaluru Medical Dialogues Bureau1 Jun 2019 9:35 AM GMTBengaluru: Drug firm AstraZeneca Thursday said it has opened a new development operations centre in Bengaluru to support the expansion of its clinical...
Amgen to buy Nuevolution for $167 million Garima26 May 2019 3:40 AM GMTAmgen, which is grappling with competition to its new migraine treatment Aimovig and cholesterol fighter Repatha, said it had collaborated with...
Lupin launches generic version of Pulmicort Respules Inhalation Suspension Farhat Nasim23 May 2019 4:00 AM GMTLupin's product is a generic version of AstraZeneca Pharmaceuticals LP's Pulmicort Respules Inhalation Suspension, 0.5 mg/2 mL.New Delhi: Drug maker...
Varian to acquire Cancer Treatment Services International for Rs 1980 crore Garima22 May 2019 4:00 AM GMTThese fast-growing offerings will allow Varian to expand its solutions while helping to support the continued growth trajectory of the company’s...
Alphabet's GV leads $58.5 million investment to launch Verve Therapeutics Garima9 May 2019 3:45 AM GMTVerve Therapeutics plans to target adults at risk of coronary artery disease, the leading cause of death worldwide, by editing their genes to mirror...
Everstone acquires stake in Chennai based CPC Diagnostics Garima14 March 2019 11:29 AM GMTThe strategic partnership with Everstone Group will help CPC Diagnostics take its product portfolio to new customers and markets, the Chennai-based...
Strides to exit investment in Arrow Pharma for over Rs 2000 crore Medical Dialogues Bureau30 Jan 2019 4:00 AM GMT"Strides will receive AUD 300 million as upfront payment at the closure of the transaction, while the balance AUD 94 million to be deferred through a...
Paras Healthcare infuses Rs 500 crore to add 830 beds in 2019 Medical Dialogues Bureau17 Jan 2019 4:15 AM GMT"We are investing Rs 500 crore to add 830 beds in 2019 across our three hospitals. This includes 232 beds in our Panchkula hospital which we have just...